Customized Chemotherapy on the Basis of EGFR Mutation Status for Elderly Patients With Advanced Non-Small-Cell Lung Cancer

被引：1
|
作者：
Kunimasa, K. [1 ]
Katakami, N. [2 ]
Masago, K. [3 ]
Yoshioka, H. [1 ]
Tomii, K. [4 ]
Kaneda, T. [5 ]
Hirabayashi, M. [6 ]
Morizane, T. [7 ]
Fujita, S. [2 ]
Mio, T. [3 ]
机构：
[1] Kurashiki Cent Hosp, Kurashiki, Okayama, Japan
[2] Inst Biomed Res & Innovat Hosp, Kobe, Hyogo, Japan
[3] Kyoto Univ Hosp, Kyoto 606, Japan
[4] Kobe City Med Ctr Gen Hosp, Kobe, Hyogo, Japan
[5] Kobe City Med Ctr W Hosp, Kobe, Hyogo, Japan
[6] Hyogo Kenritsu Amagasaki Hosp, Amagasaki, Hyogo, Japan
[7] Kanagawa Dent Coll, Kanagawa, Japan
来源：
EUROPEAN JOURNAL OF CANCER | 2011年 / 47卷
关键词：
D O I：
10.1016/S0959-8049(11)71267-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S280 / S280
页数：1
相关论文
共 50 条
  • [21] EGFR mutation status in Tunisian non-small-cell lung cancer patients evaluated by mutation-specific immunohistochemistry
    Mraihi, Zohra
    Ben Amar, Jihen
    Bouacha, Hend
    Rammeh, Soumaya
    Hila, Lamia
    [J]. BMC PULMONARY MEDICINE, 2018, 18
  • [22] EGFR mutation status in Tunisian non-small-cell lung cancer patients evaluated by mutation-specific immunohistochemistry
    Zohra Mraihi
    Jihen Ben Amar
    Hend Bouacha
    Soumaya Rammeh
    Lamia Hila
    [J]. BMC Pulmonary Medicine, 18
  • [23] Potential Benefits of Bevacizumab Combined With Platinum-Based Chemotherapy in Advanced Non-Small-Cell Lung Cancer Patients With EGFR Mutation
    Tanaka, Ichidai
    Morise, Masahiro
    Miyazawa, Ayako
    Kodama, Yuta
    Tamiya, Yutaro
    Gen, Soei
    Matsui, Akira
    Hase, Tetsunari
    Hashimoto, Naozumi
    Sato, Mitsuo
    Hasegawa, Yoshinori
    [J]. CLINICAL LUNG CANCER, 2020, 21 (03) : 273 - +
  • [24] Clinical impact of pembrolizumab combined with chemotherapy in elderly patients with advanced non-small-cell lung cancer
    Morimoto, Kenji
    Yamada, Tadaaki
    Yokoi, Takashi
    Kijima, Takashi
    Goto, Yasuhiro
    Nakao, Akira
    Hibino, Makoto
    Takeda, Takayuki
    Yamaguchi, Hiroyuki
    Takumi, Chieko
    Takeshita, Masafumi
    Chihara, Yusuke
    Yamada, Takahiro
    Hiranuma, Osamu
    Morimoto, Yoshie
    Iwasaku, Masahiro
    Kaneko, Yoshiko
    Uchino, Junji
    Takayama, Koichi
    [J]. LUNG CANCER, 2021, 161 : 26 - 33
  • [25] Increasing underrepresentation of elderly patients with advanced colorectal or non-small-cell lung cancer in chemotherapy trials
    Jennens, RR
    Giles, GG
    Fox, RM
    [J]. INTERNAL MEDICINE JOURNAL, 2006, 36 (04) : 216 - 220
  • [26] Analysis of EGFR mutation status in tissue and plasma for predicting response to EGFR-TKIs in advanced non-small-cell lung cancer
    Wang, Yuyan
    Duan, Jianchun
    Chen, Hanxiao
    Bai, Hua
    An, Tongtong
    Zhao, Jun
    Wang, Zhijie
    Zhuo, Minglei
    Wang, Shuhang
    Wang, Jie
    [J]. ONCOLOGY LETTERS, 2017, 13 (04) : 2425 - 2431
  • [27] EGFR and KRAS mutation status in non-small-cell lung cancer occurring in HIV-infected patients
    Crequit, Perrine
    Ruppert, Anne-Marie
    Rozensztajn, Nathalie
    Gounant, Valerie
    Vieira, T.
    Poulot, Virginie
    Antoine, Martine
    Chouaid, Christos
    Wislez, Marie
    Cadranel, Jacques
    Lavole, Armelle
    [J]. LUNG CANCER, 2016, 96 : 74 - 77
  • [28] Immunohistochemistry for EGFR Mutation Detection in Non-Small-Cell Lung Cancer
    Hitij, Nina Turnsek
    Kern, Izidor
    Sadikov, Aleksander
    Knez, Lea
    Stanic, Karmen
    Zwitter, Matjaz
    Cufer, Tanja
    [J]. CLINICAL LUNG CANCER, 2017, 18 (03) : E187 - E196
  • [29] Factors of interrupting chemotherapy in patients with advanced non-small-cell lung cancer
    Belbaraka R.
    Trédan O.
    Ray-Coquard I.
    Chvetzoff G.
    Bajard A.
    Pérol D.
    Ismaili N.
    Ismaili M.
    Errihani H.
    Bachelot T.
    Rebattu P.
    [J]. BMC Research Notes, 3 (1)
  • [30] EGFR mutation and resistance of non-small-cell lung cancer to gefitinib
    Kobayashi, S
    Boggon, TJ
    Dayaram, T
    Janne, PA
    Kocher, O
    Meyerson, M
    Johnson, BE
    Eck, MJ
    Tenen, DG
    Halmos, B
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (08): : 786 - 792
12345